AVXL
Price
$9.57
Change
-$0.07 (-0.73%)
Updated
Sep 2, 04:11 PM (EDT)
Capitalization
828.02M
111 days until earnings call
RAPT
Price
$11.56
Change
+$0.18 (+1.58%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
188.2M
Interact to see
Advertisement

AVXL vs RAPT

Header iconAVXL vs RAPT Comparison
Open Charts AVXL vs RAPTBanner chart's image
Anavex Life Sciences
Price$9.57
Change-$0.07 (-0.73%)
Volume$2.35K
Capitalization828.02M
RAPT Therapeutics
Price$11.56
Change+$0.18 (+1.58%)
Volume$100
Capitalization188.2M
AVXL vs RAPT Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. RAPT commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and RAPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (AVXL: $9.64 vs. RAPT: $11.38)
Brand notoriety: AVXL and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 83% vs. RAPT: 16%
Market capitalization -- AVXL: $828.02M vs. RAPT: $188.2M
AVXL [@Biotechnology] is valued at $828.02M. RAPT’s [@Biotechnology] market capitalization is $188.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, AVXL is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while RAPT’s TA Score has 3 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 6 bearish.
  • RAPT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both AVXL and RAPT are a bad buy in the short-term.

Price Growth

AVXL (@Biotechnology) experienced а +1.15% price change this week, while RAPT (@Biotechnology) price change was +0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.61%. For the same industry, the average monthly price growth was +22.15%, and the average quarterly price growth was +32.80%.

Reported Earning Dates

AVXL is expected to report earnings on Dec 22, 2025.

Industries' Descriptions

@Biotechnology (+6.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($828M) has a higher market cap than RAPT($188M). RAPT (-9.968) and AVXL (-10.242) have similar YTD gains . AVXL has higher annual earnings (EBITDA): -45.88M vs. RAPT (-111.99M). RAPT has more cash in the bank: 169M vs. AVXL (101M). AVXL has less debt than RAPT: AVXL (88.2K) vs RAPT (3.16M). AVXL (0) and RAPT (0) have equivalent revenues.
AVXLRAPTAVXL / RAPT
Capitalization828M188M440%
EBITDA-45.88M-111.99M41%
Gain YTD-10.242-9.968103%
P/E RatioN/AN/A-
Revenue00-
Total Cash101M169M60%
Total Debt88.2K3.16M3%
FUNDAMENTALS RATINGS
AVXL vs RAPT: Fundamental Ratings
AVXL
RAPT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4644
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVXL's Valuation (57) in the Biotechnology industry is in the same range as RAPT (77) in the null industry. This means that AVXL’s stock grew similarly to RAPT’s over the last 12 months.

AVXL's Profit vs Risk Rating (82) in the Biotechnology industry is in the same range as RAPT (100) in the null industry. This means that AVXL’s stock grew similarly to RAPT’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as RAPT (100) in the null industry. This means that AVXL’s stock grew similarly to RAPT’s over the last 12 months.

RAPT's Price Growth Rating (44) in the null industry is in the same range as AVXL (46) in the Biotechnology industry. This means that RAPT’s stock grew similarly to AVXL’s over the last 12 months.

RAPT's P/E Growth Rating (100) in the null industry is in the same range as AVXL (100) in the Biotechnology industry. This means that RAPT’s stock grew similarly to AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLRAPT
RSI
ODDS (%)
Bullish Trend 5 days ago
74%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 5 days ago
89%
Momentum
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
89%
MACD
ODDS (%)
Bearish Trend 6 days ago
76%
Bullish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 27 days ago
79%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAHX23.16-0.12
-0.52%
Nationwide Janus Henderson Overseas R6
HFETX57.13-0.32
-0.56%
Janus Henderson European Focus T
LCIAX215.50-1.37
-0.63%
SEI Large Cap Index A (SIIT)
TPICX14.44-0.11
-0.76%
Timothy Plan International C
TRPGX16.23-0.13
-0.79%
Nuveen Core Equity Premier

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+4.56%
PLRX - AVXL
47%
Loosely correlated
+1.23%
TENX - AVXL
45%
Loosely correlated
+1.01%
RXRX - AVXL
42%
Loosely correlated
-3.39%
MGNX - AVXL
40%
Loosely correlated
+4.12%
IDYA - AVXL
37%
Loosely correlated
-1.52%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been loosely correlated with TRAW. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPT jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-0.70%
TRAW - RAPT
45%
Loosely correlated
-1.41%
SLGL - RAPT
39%
Loosely correlated
+4.06%
AVXL - RAPT
36%
Loosely correlated
+4.56%
CTMX - RAPT
35%
Loosely correlated
-0.49%
PDSB - RAPT
33%
Loosely correlated
N/A
More